Air Liquide Supporting Critical Medical, Industrial Gas Infrastructure Needs in the U.S.

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites.
Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. For avoidance of any doubts and to make it easier, you may consider any links to external websites as sponsored links. Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

Air Liquide, a world leader in gases, technologies and services for industry and health, stands ready to support the critical efforts of the healthcare industry and U.S. government in combating the COVID-19 pandemic in the U.S. With a presence in over 80 countries globally, Air Liquide is fully mobilized to respond to the increasing need for medical oxygen and continue to service other essential businesses to bring stability to the supply chain.

Since the beginning of the coronavirus outbreak, Air Liquide in the U.S. has activated business continuity plans to maximize efficiency and maintain its activities, while increasing its medical gas production capabilities to meet the current demand. Air Liquide has been proactively communicating with medical customers, specifically hospitals, through its region-based specialists to appropriately manage the supply of the most critically needed medical gases, such as oxygen.

In addition to maintaining the highest inventory levels at customers onsite liquid medical oxygen storage units and within the fill plants of Airgas, an Air Liquide company, Air Liquide is also working to shift excess cylinder assets to areas with the greatest anticipated need and is preparing portable assets to serve the eventual oxygen needs of mobile treatment centers. Air Liquide continues to serve as a vital partner to communities and is working in partnership with local government officials to ensure an uninterrupted source of assets during this critical time. As healthcare demands increase, Air Liquide reinforces its focus on safely fulfilling the industrial gas needs of its customers in key support industries, including refining, energy, food service and pharmaceuticals.

Michael Graff, Chairman & CEO, American Air Liquide Holdings, Inc. and Air Liquide Group Executive Vice President, said: Air Liquide is honored to play a vital role in serving our healthcare system and its essential workers during this unprecedented health crisis through the reliable and safe delivery of critically important medical gases, like oxygen, and safety materials. As we navigate through these unprecedented times, Air Liquide remains committed to serve the critical needs of customers in healthcare, food, pharmaceuticals, energy and refining with excellence, so that these vital industries and services continue to operate for the good of our communities and for the resilient and sustainable growth of our economy.

A world leader in gases, technologies and services for Industry and Health, Air Liquide is present in 80 countries with approximately 67,000 employees and serves more than 3.7 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquides scientific territory and have been at the core of the companys activities since its creation in 1902.

Air Liquides ambition is to be a leader in its industry, deliver long term performance and contribute to sustainability. The companys customer-centric transformation strategy aims at profitable, regular and responsible growth over the long term. It relies on operational excellence, selective investments, open innovation and a network organization implemented by the Group worldwide. Through the commitment and inventiveness of its people, Air Liquide leverages energy and environment transition, changes in healthcare and digitization, and delivers greater value to all its stakeholders.

Air Liquides revenue amounted to 22 billion euros in 2019 and its solutions that protect life and the environment represented more than 40% of sales. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good indexes.

www.airliquide.com Follow us on Twitter @airliquidegroup

Corporate Communications

[email protected]

+33 (0)1 40 62 58 49

Air Liquide Americas Communications

Cassandra Mauel

+1 713 548-6056

Investor Relations

Paris – France

+33 (0)1 40 62 50 87

Philadelphia – USA

+1 610 263 8277